• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Product o Market segments o Comparison by Product o Consumables - Market size and forecast 2020-2025 o Equipment - Market size and forecast 2020-2025 o Market opportunity by Product • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o Asia - Market size and forecast 2020-2025 o ROW - Market size and forecast 2020-2025 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Overview o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Bio Rad Laboratories Inc. o Eurofins Scientific SE o F. Hoffmann-La Roche Ltd. o Illumina Inc. o Laboratory Corp. of America Holdings o Merck KGaA o PerkinElmer Inc. o QIAGEN NV o Takara Bio Inc. o Thermo Fisher Scientific Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2020 - 2025 ($ million) • 13: Global market: Year-over-year growth 2020 - 2025 (%) • 14: Five forces analysis 2020 & 2025 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2020 • 21: Product - Market share 2020-2025 (%) • 22: Comparison by Product • 23: Consumables - Market size and forecast 2020-2025 ($ million) • 24: Consumables - Year-over-year growth 2020-2025 (%) • 25: Equipment - Market size and forecast 2020-2025 ($ million) • 26: Equipment - Year-over-year growth 2020-2025 (%) • 27: Market opportunity by Product • 28: Customer landscape • 29: Market share By Geographical Landscape 2020-2025 (%) • 30: Geographic comparison • 31: North America - Market size and forecast 2020-2025 ($ million) • 32: North America - Year-over-year growth 2020-2025 (%) • 33: Europe - Market size and forecast 2020-2025 ($ million) • 34: Europe - Year-over-year growth 2020-2025 (%) • 35: Asia - Market size and forecast 2020-2025 ($ million) • 36: Asia - Year-over-year growth 2020-2025 (%) • 37: ROW - Market size and forecast 2020-2025 ($ million) • 38: ROW - Year-over-year growth 2020-2025 (%) • 39: Key leading countries • 40: Market opportunity By Geographical Landscape ($ million) • 41: Impact of drivers and challenges • 42: Vendor landscape • 43: Landscape disruption • 44: Industry risks • 45: Vendors covered • 46: Market positioning of vendors • 47: Bio Rad Laboratories Inc. - Overview • 48: Bio Rad Laboratories Inc. - Business segments • 49: Bio Rad Laboratories Inc. - Key offerings • 50: Bio Rad Laboratories Inc. - Key customers • 51: Bio Rad Laboratories Inc. - Segment focus • 52: Eurofins Scientific SE - Overview • 53: Eurofins Scientific SE - Business segments • 54: Eurofins Scientific SE - Key offerings • 55: Eurofins Scientific SE - Key customers • 56: Eurofins Scientific SE - Segment focus • 57: F. Hoffmann-La Roche Ltd. - Overview • 58: F. Hoffmann-La Roche Ltd. - Business segments • 59: F. Hoffmann-La Roche Ltd. - Key offerings • 60: F. Hoffmann-La Roche Ltd. - Key customers • 61: F. Hoffmann-La Roche Ltd. - Segment focus • 62: Illumina Inc. - Overview • 63: Illumina Inc. - Product and service • 64: Illumina Inc. - Key offerings • 65: Illumina Inc. - Key customers • 66: Illumina Inc. - Segment focus • 67: Laboratory Corp. of America Holdings - Overview • 68: Laboratory Corp. of America Holdings - Business segments • 69: Laboratory Corp. of America Holdings - Key offerings • 70: Laboratory Corp. of America Holdings - Key customers • 71: Laboratory Corp. of America Holdings - Segment focus • 72: Merck KGaA - Overview • 73: Merck KGaA - Business segments • 74: Merck KGaA - Key offerings • 75: Merck KGaA - Key customers • 76: Merck KGaA - Segment focus • 77: PerkinElmer Inc. - Overview • 78: PerkinElmer Inc. - Business segments • 79: PerkinElmer Inc. - Key offerings • 80: PerkinElmer Inc. - Key customers • 81: PerkinElmer Inc. - Segment focus • 82: QIAGEN NV - Overview • 83: QIAGEN NV - Business segments • 84: QIAGEN NV - Key offerings • 85: QIAGEN NV - Key customers • 86: QIAGEN NV - Segment focus • 87: Takara Bio Inc. - Overview • 88: Takara Bio Inc. - Business segments • 89: Takara Bio Inc. - Key offerings • 90: Takara Bio Inc. - Key customers • 91: Takara Bio Inc. - Segment focus • 92: Thermo Fisher Scientific Inc. - Overview • 93: Thermo Fisher Scientific Inc. - Business segments • 94: Thermo Fisher Scientific Inc. - Key offerings • 95: Thermo Fisher Scientific Inc. - Key customers • 96: Thermo Fisher Scientific Inc. - Segment focus • 97: Currency conversion rates for US$ • 98: Research Methodology • 99: Validation techniques employed for market sizing • 100: Information sources • 101: List of abbreviations

Bio Rad Laboratories Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina Inc., Laboratory Corp. of America Holdings, Merck KGaA, PerkinElmer Inc., QIAGEN NV, Takara Bio Inc., Thermo Fisher Scientific Inc.